Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1) (Middle Region) Peptide
Quick Overview for Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1) (Middle Region) Peptide (ABIN985104)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- NLIHEPLDQG NCAGSWAFST AAVASDRVSI HSLGHMTPVL SPQNLLSCDT
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-TINAGL1 Antibody(ARP57621_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- TINAGL1 (Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1))
-
Background
-
TINAGL1 may be implicated in the adrenocortical zonation and in mechanisms for repressing the CYP11B1 gene expression in adrenocortical cells. This is a non catalytic peptidase C1 family protein.
Alias Symbols: ARG1, LCN7, LIECG3, TINAGRP
Protein Interaction Partner: CAPN1,CAPN1,LMO4,MDFI,MED31,SMAD9,UTP14A,MDFI,MED31,UTP14A
Protein Size: 467 -
Molecular Weight
- 52 kDa
-
Gene ID
- 64129
-
NCBI Accession
- NM_022164, NP_071447
-
UniProt
- Q9GZM7
Target
-